Mitchell Chan

Insider Reports History

Entity
Individual
Location
C/O Viela Bio, Inc., One Medimmune Way, First Floor, Area Two, Gaithersburg, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mitchell Chan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Financial Officer Common Stock 58.9K $726K $12.34 Sep 16, 2024 Direct
Avalo Therapeutics, Inc. Director Restricted Stock Units 9.5K $4.93K $0.52 Aug 13, 2024 Direct
REGENXBIO Inc. Chief Financial Officer Stock Options (Right to buy) 289K Sep 16, 2024 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 24.6K Aug 13, 2024 Direct

Insider Reports Filed by Mitchell Chan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Sep 16, 2024 2 $0 4 Sep 18, 2024 Chief Financial Officer
RGNX REGENXBIO Inc. Sep 16, 2024 0 $0 3 Sep 18, 2024 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Aug 13, 2024 2 $0 4 Aug 14, 2024 Director
AVTX Avalo Therapeutics, Inc. Dec 20, 2023 1 $0 4 Dec 21, 2023 Director
AVTX Avalo Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
AVTX Avalo Therapeutics, Inc. Dec 1, 2021 1 $0 4 Dec 3, 2021 Director
AVTX Avalo Therapeutics, Inc. Dec 1, 2021 0 $0 3 Dec 3, 2021 Director